| DB ID | MyCo_1017 |
| Title | Candida albicans biofilm formation is associated with increased anti-oxidative capacities |
| Year | 2008 |
| PMID | 18655069 |
| Fungal Diseases involved | Candida albicans infection |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | None |
| Site of Infection | Mouth |
| Opportunistic invasive | Opportunistic |
| Sample type | Biopsy |
| Sample source | Extracted Protein |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | NADH-cytochrome b5 reductase |
| Biomarker Full Name | NADH-cytochrome b5 reductase |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | None |
| Cohort No. | None |
| Age Group | None |
| P Value | p=0.099 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | 2.3 fold |
| Pathway | None |
| Disease Introduction Mechanism | Candida is the major opportunistic fungal pathogen that causes diseases varying from superficial mucosal infections to life-threatening systemic disorders of humans. For instance Candida infections are a leading cause of nosoco- mial disease with a mortality rate as high as 40%. Moreover, Candida causes significant morbidity and mortal-ity in compromised populations such as HIV/AIDS patients, organ transplant recipients, and patients on chemother- apeutic agents. |
| Technique | PCR |
| Analysis Method | 2-DE-based Proteomics approach and RT-PCR |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | 2-DE-based Proteomics approach and RT-PCR |
| Up Regulation Down Regulation | Differentially Expressed |
| Sequence Data | None |
| External Link | None |
